FDA approves Fonar open scanner

Article

Fonar introduced its “Open Sky” scanner room two years ago at the Radiological Society of North America meeting, and this month the Melville, NY-based company moved one step closer to putting the system on the market.The Food and Drug

Fonar introduced its “Open Sky” scanner room two years ago at the Radiological Society of North America meeting, and this month the Melville, NY-based company moved one step closer to putting the system on the market.

The Food and Drug Administration has given Fonar premarket approval for the Fonar 360, which is the platform scanner for the Open Sky. The Fonar 360 will have a 0.6-tesla field strength.

Fonar says the company has ushered in a new era of patient friendliness in MR with its work-in-progress Open Sky room. Patients will walk into the scanner room in which two circular structures projecting from the ceiling and floor are the only objects. There’s nothing else—no posts, no tube they must climb into—between the patient and the scanner room walls.

The walls are decorated with a landscape scene, and the room is quiet thanks to Fonar’s patented sound-dampening system. Patients will also be able to choose which landscape setting they would like. The large circular structures that the patient sees as part of the landscape are the poles of the scanner’s magnet.

Last year, healthcare services contributed more to Fonar’s revenue than scanner sales.

During its 1999 fiscal year (end-June), Fonar posted revenue of $36.9 million, a 34% increase over 1998’s $27.6 million, but also sustained a net loss of $14.2 million. Fonar attributed the loss to low scanner sales and expenses related to the R&D of four new MRI products (SCAN 11/10/99). Fonar believes that its new scanners, including the Open Sky, will lead to sales growth (SCAN 3/3/99).

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.